Update on Medication-Overuse Headache and Its Treatment

被引:15
作者
Giamberardino, Maria Adele [1 ,2 ]
Mitsikostas, Dimos-Dimitrios [3 ]
Martelletti, Paolo [4 ]
机构
[1] Univ G DAnnunzio, Dept Med & Sci Aging, Headache Ctr, I-66100 Chieti, Italy
[2] Univ G DAnnunzio, Dept Med & Sci Aging, Geriatr Clin, I-66100 Chieti, Italy
[3] Athens Naval Hosp, Dept Neurol, Athens 11521, Greece
[4] Univ Roma La Sapienza, St Andrea Hosp, Reg Referral Headache Ctr, Dept Clin & Mol Med, I-00189 Rome, Italy
关键词
Medication-overuse headache; Chronic migraine; Relapse; Drug withdrawal; Detoxification; Re-prophylaxis; OnabotulinumtoxinA; Topiramate; STRUCTURED DETOXIFICATION PROGRAMS; PLACEBO-CONTROLLED PHASE; TOXIN TYPE-A; CHRONIC MIGRAINE; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; WITHDRAWAL HEADACHE; FOLLOW-UP; ONABOTULINUMTOXINA; TOPIRAMATE;
D O I
10.1007/s11940-015-0368-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Medication-overuse headache-i.e., a too-frequent consumption of acute headache medications leading to increased headache frequency and reduced effectiveness of acute and preventive treatments-is a serious medical condition whose pathophysiology still remains incompletely known, which is reflected into a lack of mechanism-based treatments. The first mandatory step in the therapeutic strategy remains withdrawal of the abused drug, preferably abrupt, in concomitance with a detoxification pharmacological regimen to lessen withdrawal symptoms. Intravenous hydration, antiemetics, corticosteroids (prednisone), tranquilizers (benzodiazepine), neuroleptics, and rescue medication (another analgesic than the overused) should be delivered in various combinations, on an inpatient (hospitalization and day hospital) basis or outpatient basis, depending on the characteristics of the specific patient and type of overuse. Inpatient withdrawal should be preferred in barbiturate and opioid overuse, in concomitant depression, or, in general, in patients who have difficulty in stopping the overused medication as outpatients. In contrast, in overuse limited to simple analgesics in highly motivated patients, without high levels of depression and/or anxiety, home detoxification should be chosen. Re-prophylaxis should immediately follow detoxification, ideally with local injections of onabotulinumtoxinA every 3 months or topiramate orally for at least 3 months. Adequate information to patients about the risks of a too-frequent consumption of symptomatic headache medications is essential and should constantly parallel treatment to help preventing relapse after detoxification and re-prophylaxis.
引用
收藏
页数:15
相关论文
共 83 条
[1]   Disability in chronic migraine with medication overuse: Treatment effects through 5 years [J].
Andrasik, F. ;
Grazzi, L. ;
Usai, S. ;
Kass, S. ;
Bussone, G. .
CEPHALALGIA, 2010, 30 (05) :610-614
[2]   Cervical 10kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study [J].
Arcioni, R. ;
Palmisani, S. ;
Mercieri, M. ;
Vano, V. ;
Tigano, S. ;
Smith, T. ;
Fiore, M. R. D. ;
Al-Kaisy, A. ;
Martelletti, P. .
EUROPEAN JOURNAL OF PAIN, 2016, 20 (01) :70-78
[3]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[4]   LONGTERM PROGNOSIS OF ANALGESIC WITHDRAWAL IN PATIENTS WITH DRUG-INDUCED HEADACHES [J].
BAUMGARTNER, C ;
WESSELY, P ;
BINGOL, C ;
MALY, J ;
HOLZNER, F .
HEADACHE, 1989, 29 (08) :510-514
[5]   EFNS guideline on the treatment of tension-type headache - Report of an EFNS task force [J].
Bendtsen, L. ;
Evers, S. ;
Linde, M. ;
Mitsikostas, D. D. ;
Sandrini, G. ;
Schoenen, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (11) :1318-E102
[6]   Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program [J].
Blumenfeld, Andrew ;
Silberstein, Stephen D. ;
Dodick, David W. ;
Aurora, Sheena K. ;
Turkel, Catherine C. ;
Binder, William J. .
HEADACHE, 2010, 50 (09) :1406-1418
[7]   Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP [J].
Boe, M. G. ;
Salvesen, R. ;
Mygland, A. .
CEPHALALGIA, 2009, 29 (08) :855-863
[8]   Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy [J].
Boe, M. G. ;
Salvesen, R. ;
Mygland, A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) :705-712
[9]   Prednisolone does not reduce withdrawal headache -: A randomized, double-blind study [J].
Boe, Magne G. ;
Mygland, Ase ;
Salvesen, Rolf .
NEUROLOGY, 2007, 69 (01) :26-31
[10]   A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine [J].
Cady, Roger K. ;
Schreiber, Curtis P. ;
Porter, John A. H. ;
Blumenfeld, Andrew M. ;
Farmer, Kathleen U. .
HEADACHE, 2011, 51 (01) :21-32